GSC
CBMG

Ground Swell Capital’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Ground Swell Capital’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1K Buy
+65
New +$1.32K ﹤0.01% 2256

Other funds holding CBMG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

Ground Swell Capital's CBMG Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Cellular Biomedicine Group, Inc. (CBMG) in Q3 2014: 65 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2256 among its holdings.

7 funds tracked by Wall St. Rank hold CBMG as of Q3 2014.

  • Ground Swell Capital held 65 shares of Cellular Biomedicine Group, Inc. worth $1K as of Q3 2014.
  • Cellular Biomedicine Group, Inc. was a new Ground Swell Capital position in Q3 2014.
  • Cellular Biomedicine Group, Inc. made up ﹤0.01% of Ground Swell Capital's portfolio in Q3 2014, its #2256 holding.
  • 7 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.